Stanford University to undertake Alzheimer's disease study

10/13/2010 |

Researchers at the Stanford University School of Medicine are looking for volunteers for a Phase III trial that will focus on improving a diagnostic method for Alzheimer's disease. In the study, participants will be injected with the imaging agent florbetaben before undergoing a PET scan to measure beta-amyloid plaque accumulation.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care